Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case

Johnson & Johnson (JNJ) was ordered on Thursday by a jury in Missouri to pay $4.69 billion in damages to 22 women who claimed the company's baby powder contained asbestos that caused their ovarian cancer.

The jury award in the case included $550 million in compensatory damages and $4.14 billion in punitive damages, according to a statement from the attorneys representing the plaintiffs.

Johnson & Johnson shares fell $3.01, or 2.36%, in after-hours trading.

The company faces more than 9,000 cases over body powders containing talc, according to its latest quarterly filing with the SEC.

In a statement, the company said it would appeal the verdict, "which was the product of a fundamentally unfair process that allowed plaintiffs to present a group of 22 women, most of whom had no connection to Missouri, in a single case all alleging that they developed ovarian cancer."

More from Investing

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

Closed-End Real Estate Funds Are Performing Well

Closed-End Real Estate Funds Are Performing Well

Successfully Plan for Retirement With a Triple-Tax-Free Health Savings Account

Successfully Plan for Retirement With a Triple-Tax-Free Health Savings Account

Mike Novogratz: A 'Herd of Institutional Investors' Is Moving Into Crypto

Mike Novogratz: A 'Herd of Institutional Investors' Is Moving Into Crypto

Fornite Funko Pop Toys Will Be Huge: CEO

Fornite Funko Pop Toys Will Be Huge: CEO